Clinical Trial Update: Gadopiclenol in Contrast Enhanced MRI of the Prostate [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating gadopiclenol as a contrast agent for MRI in prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• gadopiclenol (gadopiclenol)

Snippet

Sponsor: Columbia University | Conditions: Prostate Cancer | Phase 4 | Status: RECRUITING